IND packages to take your compound to the finish line.

A proper IND application must contain robust information in three broad areas[1]:

  1. Animal pharmacology and toxicology studies that provide enough data to assess whether the product is safe enough to be used for initial testing in humans. Any previous experience with the drug in humans is also included.
  2. Manufacturing information showing the composition of the compound, the manufacturer, the stability and the controls that were used to manufacture the drug. 
  3. Clinical protocols and investigator information: The detailed protocols allow for proper risk assessment of the initial phase trials. The information on the qualifications of the investigators to assess they are qualified to fulfill their clinical trial duties. 

Submitting an IND application can seem like one of the most demanding and stressful steps in your compound’s journey. With PharmaLegacy by your side, no need to worry. With over 400 FDA / CFDA IND filings in our portfolio, the deep experience of our pharmacology experts, and our unwavering work ethic, your compound will make it all the way to the finish line in no time!

Contact Us
Candidate Screening / IND package

Extensively validated preclinical models:

  • Completed over 400 FDA / CFDA IND filings
  • Scientific staff with an average of over 15 years of experience in pharmacology
  • 24/7 access to PharmaLegacy representatives
  • Capacity to house over 30,000 rodents and large animals

PharmaLegacy will accelerate your success with no compromise to the quality of your pipeline. You’ve come to the right place. Contact us now.

Contact Us

We’re ready when you are.

Tell us your pharmacology challenges.